Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitalipid Infant
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
Vitalipid Infant (also known as Vitalipid N Infant) is a sterile oil-in-water emulsion for intravenous use, developed by Baxter and distributed by Fresenius Kabi. It is indicated as a supplement in complete parenteral nutrition to meet the daily requirements of fat-soluble vitamins A, D2, E, and K1 in neonates, infants, and children up to 11 years of age. The product contains retinol, ergocalciferol, alpha-tocopherol, and phytomenadione in a lipid vehicle of soya oil and egg lecithin. It is typically administered by addition to a lipid emulsion such as Intralipid. Vitalipid Infant serves as a standard of care in pediatric parenteral nutrition and has been used as a comparator in clinical trials for new parenteral vitamin formulations.
- Brand names
- Vitalipid InfantVitalipid N Infant
- Other names
- Vitalipid InfantVitalipid N Infant
02
Targets
GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)RAR (Retinoic acid receptor)
Beyond the preview
Go deeper on Vitalipid Infant.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitalipid Infant.